Condition
Endometrial Cancer Recurrent clinical trials and research
Research outlook What's coming for Endometrial cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Endometrial Cancer Recurrent clinical trials that are recruiting, at sites in 3 countries (most in China (2), Netherlands (1), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Endometrial Cancer Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| OPB-201 therapy for recurrent endometrial and platinum-resistant ovarian cancer | Phase 1 | San Francisco, California and 4 other locations | Recruiting | Jun 24, 2026 |
| Exploring personalized treatment for recurrent gynecological cancers | — | Guangzhou, Guangdong and 1 other locations | Recruiting | Jan 17, 2025 |
| CAR-NK cell therapy for advanced solid tumors | Phase 1 | Guangzhou, Guangdong | Recruiting | Jun 8, 2022 |
| Optimizing hormonal therapy for advanced and recurrent endometrial cancer | — | Nijmegen | Recruiting | Aug 9, 2018 |
All recruiting trials (4)
-
OPB-201 therapy for recurrent endometrial and platinum-resistant ovarian cancer
A one-time treatment with a patient’s own T cells engineered to target PRAME is being tested to see if it is safe and what dose works best for adults with recurrent endometrial cancer or platinum-resistant ovarian cancer.
-
Exploring personalized treatment for recurrent gynecological cancers
This study is testing if using genetic information to guide treatment can help improve outcomes for people with recurrent ovarian, cervical, or endometrial cancer.
-
CAR-NK cell therapy for advanced solid tumors
This study is testing a new treatment using specially modified immune cells to see if they can help people with advanced solid tumors like ovarian and testis cancers.
-
Optimizing hormonal therapy for advanced and recurrent endometrial cancer
This study is trying to find better ways to use hormonal therapy for women with advanced or recurring endometrial cancer by looking at their tumor samples to see who might benefit most from this treatment.
Related topics
Quick answers
How many Endometrial Cancer Recurrent clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Netherlands (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.